The APOA5*2 haplotype, determined by the minor alleles of rs662799, rs2072560, and rs2266788, has been associated with elevated TG levels and risk for the development of MS [11-13], while the APOA5*3 haplotype, determined by the minor allele of rs3135506, has been shown to associate with increased levels of TG [4,5]. This evidence concerns the gene APOA5 and myeloid sarcoma.